1,721,056 research outputs found
sj-docx-1-tan-10.1177_17562864241239101 – Supplemental material for Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis
No full textSupplemental material, sj-docx-1-tan-10.1177_17562864241239101 for Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis by Jens Kuhle, David Leppert, Giancarlo Comi, Nicola de Stefano, Ludwig Kappos, Mark S. Freedman, Andrea Seitzinger and Sanjeev Roy in Therapeutic Advances in Neurological Disorders</p
MSJ765666_supplementary_figure_1 – Supplemental material for Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
No full textSupplemental material, MSJ765666_supplementary_figure_1 for Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis by Nelly Siller, Jens Kuhle, Muthuraman Muthuraman, Christian Barro, Timo Uphaus, Sergiu Groppa, Ludwig Kappos, Frauke Zipp and Stefan Bittner in Multiple Sclerosis Journal</p
MSJ768433_supplementary_material – Supplemental material for Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing–remitting multiple sclerosis
No full textSupplemental material, MSJ768433_supplementary_material for Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing–remitting multiple sclerosis by Johannes Lorscheider, Pascal Benkert, Carmen Lienert, Peter Hänni, Tobias Derfuss, Jens Kuhle, Ludwig Kappos and Özgür Yaldizli in Multiple Sclerosis Journal</p
MSJ901272_supplemental_figures – Supplemental material for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis
No full textSupplemental material, MSJ901272_supplemental_figures for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis by Barbora Srpova, Tomas Uher, Tereza Hrnciarova, Christian Barro, Michaela Andelova, Zuzanna Michalak, Manuela Vaneckova, Jan Krasensky, Libuse Noskova, Eva Kubala Havrdova, Jens Kuhle and Dana Horakova in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585221144742 – Supplemental material for Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221144742 for Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial by Jens Kuhle, Tanuja Chitnis, Brenda Banwell, Marc Tardieu, Douglas L Arnold, Andreea M Rawlings, Svend S Geertsen, Alex L Lublin, Stephane Saubadu, Philippe Truffinet and Ludwig Kappos in Multiple Sclerosis Journal</p
MSJ901272_supplemental_tables – Supplemental material for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis
No full textSupplemental material, MSJ901272_supplemental_tables for Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis by Barbora Srpova, Tomas Uher, Tereza Hrnciarova, Christian Barro, Michaela Andelova, Zuzanna Michalak, Manuela Vaneckova, Jan Krasensky, Libuse Noskova, Eva Kubala Havrdova, Jens Kuhle and Dana Horakova in Multiple Sclerosis Journal</p
sj-pdf-1-tpx-10.1177_01926233231180179 – Supplemental material for Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity
No full textSupplemental material, sj-pdf-1-tpx-10.1177_01926233231180179 for Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity by Diethilde Theil, Jens Kuhle, Dominique Brees, Elaine Tritto, François Pognan, Wilfried Frieauff, Kelley Penraat, Emily Meseck, Reginald Valdez and Andreas Hartmann in Toxicologic Pathology</p
sj-pdf-1-msj-10.1177_13524585231221938 – Supplemental material for Use of pragmatic randomized trials in multiple sclerosis: A systematic overview
No full textSupplemental material, sj-pdf-1-msj-10.1177_13524585231221938 for Use of pragmatic randomized trials in multiple sclerosis: A systematic overview by Julian Hirt, Perrine Janiaud, Pascal Düblin, Giovanni Jacopo Nicoletti, Kinga Dembowska, Thao Vy Thi Nguyen, Tim Woelfle, Cathrine Axfors, Özgür Yaldizli, Cristina Granziera, Jens Kuhle, Ludwig Kappos and Lars G Hemkens in Multiple Sclerosis Journal</p
sj-tiff-1-msj-10.1177_13524585211047977 – Supplemental material for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis
No full textSupplemental material, sj-tiff-1-msj-10.1177_13524585211047977 for Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis by Tomas Uher, Eva Kubala Havrdova, Pascal Benkert, Niels Bergsland, Jan Krasensky, Barbora Srpova, Michael Dwyer, Michaela Tyblova, Stephanie Meier, Manuela Vaneckova, Dana Horakova, Robert Zivadinov, David Leppert, Tomas Kalincik and Jens Kuhle in Multiple Sclerosis Journal</p
sj-pdf-2-tan-10.1177_17562864221080528 – Supplemental material for Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response
No full textSupplemental material, sj-pdf-2-tan-10.1177_17562864221080528 for Neuro-axonal injury in COVID-19: the role of systemic inflammation and SARS-CoV-2 specific immune response by Cédric Hirzel, Denis Grandgirard, Bernard Surial, Manon F. Wider, David Leppert, Jens Kuhle, Laura N. Walti, Joerg C. Schefold, Thibaud Spinetti, Franziska Suter-Riniker, Ronald Dijkman and Stephen L. Leib in Therapeutic Advances in Neurological Disorders</p
- …
